Synergistic cytotoxic effects of tamoxifen and black cohosh on MCF-7 and MDA-MB-231 human breast cancer cells: An in vitro study

Canadian Journal of Physiology and Pharmacology

Volumn 85, Issue 11, 2007, Pages 1153-1159

  Al Akoum, Mahéra ^a   Dodin, Sylvie ^a   Akoum, Ali ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Black cohosh; Breast cancer; Cell growth assay; Cimicifuga racemosa; Hormone replacement therapy; In vitro; MCF 7 cells; MDA MB 231 cells; Menopausal symptoms; Tamoxifen

Indexed keywords

ESTRADIOL; ESTROGEN; HERBACEOUS AGENT; SULFORHODAMINE B; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CELL STIMULATION; CELL STRAIN MCF 7; CIMICIFUGA RACEMOSA; CYTOTOXICITY; DOSE RESPONSE; DRUG POTENTIATION; HERBAL MEDICINE; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; POWDER; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CIMICIFUGA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ESTRADIOL; HUMANS; PHYTOTHERAPY; TAMOXIFEN;

EID: 38849143081     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y07-111     Document Type: Article

References (27)

1. Barakat, R.R. 1996. Tamoxifen and Endometrial Cancer. Cancer Control, 3: 107-112.
2. Beuscher, N. 1995. Cimicifuga racemosa L.: Die Traubensilberkerze. Z. Phytother. 16: 301-310.
3. Bodinet, C., and Freudenstein, J. 2002. Influence of Cimicifuga racemosa on the proliferation of estrogen receptor-positive human breast cancer cells. Breast Cancer Res. Treat. 76: 1-10. doi:10.1023/A: 1020241509382.
4. Bodinet, C., and Freudenstein, J. 2004. Influence of marketed herbal menopause preparations on MCF-7 cell proliferation. Menopause, 11: 281-289. doi:10.1097/01.GME.0000094209.15096.2B.
5. Brummer, S.A. 1997. Remifemin, a plant-based gynecological agent. Salzgitter, Germany. pp. 1-38.
6. Davis, V.L., Jayo, M.J., Hardy, M.L., Ho, A., Lee, H., Shaikh, F., et al. 2003. Effects of black cohosh on mammary tumor development and progression in MMTV-neu transgenic mice. Proc. Am. Assoc. Cancer Res. 44: R910. [Abstr.]
7. Dixon-Shanies, D., and Shaikh, N. 1999. Growth inhibition of human breast cancer cells by herbs and phytoestrogens. Oncol. Rep. 6: 1383-1387.
8. Eisenberg, D.M., Davis, R.B., Ettner, S.L., Appel, S., Wilkey, S., Van Rompay, M., et al. 1998. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA, 280: 1569-1575. doi:10.1001/jama.280.18.1569.
9. Foster, S. 1999. Black cohosh (Cimicifuga racemosa): a literature review. HerbalGram, 45: 35-49.
10. Fuqua, S.A., Schiff, R., Parra, I., Friedrichs, W.E., Su, J.L., McKee, D.D., et al. 1999. Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer. Cancer Res. 59: 5425-5428.
11. Gruenwald, J. 1998. Standardized black cohosh (Cimicifuga) Extract Clinical Monograph. Herbal Research Review. pp. 117-125.
12. Jarry, H., and Harnischfeger, G. 1985. Endocrine effects of constituents of Cimicifuga racemosa. 1. The effect on serum levels of pituitary hormones in ovariectomized rats. Planta Med. 1: 46-49.
13. Jarry, H., Harnischfeger, G., and Duker, E. 1985. The endocrine effects of constituents of Cimicifuga racemosa. 2. In vitro binding of constituents to estrogen receptors. Planta Med. 4: 316-319.
14. Li, J.X., and Yu, Z.Y. 2006. Cimicifugae rhizoma: from origins, bioactive constituents to clinical outcomes. Curr. Med. Chem. 13: 2927-2951. doi:10.2174/092986706778521869.
15. Liske, E. 1998. Therapeutic efficacy and safety of Cimicifuga racemosa for gynecologic disorders. Adv. Ther. 15: 45-53.
16. Liske, E., and Wustenberg, P. 1998. Therapy of climacteric complaints wiyh cimicifuga racemosa:herbal medicine with clinically proven evidence. Menopause, 5: 250. doi:10.1097/00042192-199805040-00051.
17. Liske, E., Hanggi, W., Henneicke-von Zepelin, H.H., Boblitz, N., Wustenberg, P., and Rahlfs, V.W. 2002. Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect. J. Womens Health Gend. Based Med. 11: 163-174. doi:10.1089/152460902753645308.
18. Love, R.R., Cameron, L., Connell, B.L., and Leventhal, H. 1991. Symptoms associated with tamoxifen treatment in postmenopausal women. Arch. Intern. Med. 151: 1842-1847. doi:10.1001/archinte.151.9.1842.
19. Munoz, G.H., and Pluchino, S. 2003. Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer. Maturitas, 44: S59-S65.
20. NeBelhut, T., Schellhase, T., and Dietrich, C. 1993. Untersuchungen Zur proliferativen Potenz von Phytopharmaka mit ôstrogenâhnlicher Wirkung bei Mammakarzinomzellen. Arch. Gynecol. Obstet. 254: 817-818.
21. Santen, R.J., and Harvey, H.A. 1999. Use of aromatase inhibitors in breast carcinoma. Endocr. Relat. Cancer, 6: 75-92. doi:10.1677/erc.0. 0060075.
22. Seifert, M., Galid, A., and Kubista, E. 1999. Estrogen replacement therapy in women with a history of breast cancer. Maturitas, 32: 63-68. doi:10.1016/S0378-5122(98)00107-8.
23. Wang, C., and Kurzer, M.S. 1998. Effects of phytoestrogens on DNA synthesis in MCF-7 cells in the presence of estradiol or growth factors. Nutr. Cancer, 31: 90-100.
24. Winterhoff, H., Spengler, B., Christoffel, V., Butterweck, V., and Lohning, A. 2003. Cimicifuga extract BNO 1055: reduction of hot flushes and hints on antidepressant activity. Maturitas, 44 (Suppl. 1): S51-S58. doi:10.1016/S0378-5122(02)00348-1.
25. Wuttke, W., Seidlova-Wuttke, D., and Gorkow, C. 2003. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas, 44 (Suppl. 1): S67-S77. doi:10.1016/S0378-5122(02) 00350-X.
26. Zava, D.T., Dollbaum, C.M., and Blen, M. 1998. Estrogen and progestin bioactivity of foods, herbs, and spices. Proc. Soc. Exp. Biol. Med. 217: 369-378.
27. Zhang, L., Khan, I.A., Willett, K.L., and Foran, C.M. 2003. In vivo effects of black cohosh and genistein on estrogenic activity and lipid peroxidation in Japanese Medaka (Oryzias latipes). J. Herb. Pharmacother. 3: 33-50.